Finally, having shown that TGFβ inhibits stemness and prevents tumor formation, progression and metastasis, our study underscores the potential for using TGFβ-mimicking or stimulating agents as new therapeutics for cutaneous melanoma. Here, TGFB1 is linked to cutaneous melanoma.